$70.70
-0.54-0.76%
Pre-Market: 6:51 PM EDT
AstraZeneca reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of AstraZeneca using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-12 | $1.04 | $1.03 | 0.97 % |
Q2 | 2024-07-25 | $0.99 | $1.20 | -17.5 % |
Q1 | 2024-04-25 | $1.03 | $1.22 | -15.6 % |
Q4 | 2024-02-08 | $0.73 | $0.79 | -8.23 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-12 | $13.57B | $13.09B | 3.63 % |
Q2 | 2024-07-25 | $12.98B | $12.75B | 1.83 % |
Q1 | 2024-04-25 | $12.68B | $11.83B | 7.18 % |
Q4 | 2024-02-08 | $12.02B | $12.09B | -0.55 % |
AstraZeneca (AZN) is scheduled to report earnings on April 24, 2025. The last reported earnings were for reported on November 12, 2024 for Q3.
The Actual EPS was $1.04, which beat the estimate of $1.03.
The Actual Revenue was $13.6B, which beat the estimate of $13.1B.
Browse earnings estimates, EPS, and revenue on all stocks.